OSE Immunotherapeutics Eulerpool News

OSE Immunotherapeutics Eulerpool News

OSE Immunotherapeutics Aktie News

OSE Immunotherapeutics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten OSE Immunotherapeutics News stellen wir hier zusammen.

• 16. April ·

  Yahoo
  OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation Becomes Effective
• 10. April ·

  Yahoo
  OSE Immunotherapeutics Receives €8.4 M in Public Funding to Support the Registration Phase 3 Clinical Trial of Cancer Vaccine Tedopi® in Lung Cancer
• 2. April ·

  Yahoo
  OSE Immunotherapeutics Announces Peer-Reviewed Publication on Novel Myeloid Immune Checkpoint CLEC-1 in Journal of Immunology
• 27. März ·

  Yahoo
  OSE Immunotherapeutics Reports Full Year 2023 Financial Results and Provides Business Strategy Update
• 18. März ·

  Yahoo
  OSE Immunotherapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial Evaluating Lusvertikimab in Patients with Ulcerative Colitis
• 29. Februar ·

  Yahoo
  Pharma Stock Roundup: FDA Priority Tag to SNY, ABBV Filings, CHMP Nod for AZN, JNJ, MRK
• 28. Februar ·

  Yahoo
  OSE Immunotherapeutics to Host a Live Webcast to Discuss AbbVie Global Partnership
• 28. Februar ·

  Yahoo
  AbbVie and OSE Immunotherapeutics Announce Partnership to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation
• 26. Februar ·

  Yahoo
  OSE Immunotherapeutics Provides Update on Clinical Results With OSE-279 in Advanced Solid Tumors
• 19. Januar ·

  Yahoo
  OSE Immunotherapeutics Highlights Clinical Portfolio Advancements and Provides 2024 Outlook